The neuroendocrine axis in patients with multiple sclerosis

Brain

Volumn 120, Issue 6, 1997, Pages 1067-1076

  Wei, Terence ^a   Lightman, Stafford L ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diurnal rhythm; Hypothalamo pituitary adrenal axis; Multiple sclerosis

Indexed keywords

BETA ENDORPHIN; C REACTIVE PROTEIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ESTRADIOL BLOOD LEVEL; FATIGUE; FEEDBACK SYSTEM; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROENDOCRINE SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROTEIN BLOOD LEVEL; RELAPSE; TESTOSTERONE BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0030977088     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.6.1067     Document Type: Article

References (49)

1. Alexander L, Cass LJ. ACTH-induced adrenocortical response patterns in multiple sclerosis and their relation to the clinical effectiveness of ACTH therapy. Confin Neurol 1971; 33: 1-24.
2. Bolton C, Flower RJ. The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci 1989; 45: 97-104.
3. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, et al. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992; 55: 600-8.
4. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis [see comments]. Arthritis Rheum 1992; 35: 1281-8. Comment in: Arthritis Rheum 1993; 36: 1334-5.
5. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis [see comments]. Arthritis Rheum 1992; 35: 1281-8. Comment in: Arthritis Rheum 1993; 36: 1334-5.
6. Erkut ZA, Hofman MA, Ravid R, Swaab DF. Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 1995; 62: 27-33.
7. Fog T. ACTH in therapy of multiple sclerosis. Nord Med 1951; 46: 1742-8.
8. Frei K, Fredrikson S, Fontana A, Link H. Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol 1991; 31: 147-53.
9. Giovannoni G, Thorpe JW, Kidd D, Kendall BE, Moseley IF, Thompson AJ, et al. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry 1996; 60: 20-6.
10. Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol 1996; 104: 31-7.
11. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med 1989; 226: 241-4.
12. Gudbjörnsson B, Skogseid B, Öberg K, Wide L. Hällgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids [see comments]. J Rheumatol 1996; 23: 596-602. Comment in: J Rheumatol 1996; 23: 577-81.
13. Gudbjörnsson B, Skogseid B, Öberg K, Wide L. Hällgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids [see comments]. J Rheumatol 1996; 23: 596-602. Comment in: J Rheumatol 1996; 23: 577-81.
14. Hall R, Anderson J, Smart GA, Besser M. Appendix D. Tests of adrenocortical function. In: Hall R, Anderson J, Smart GA, Besser M. Fundamentals of clinical endocrinology. 3rd ed. Tunbridge Wells (UK): Pitman Medical, 1980: 752-4.
15. Jara LJ, Lavalle C, Fraga A, Gómez-Sanchez C, Silveira LH, Martinez-Osuna P, et al. Prolactin, immunoregulation, and autoimmune diseases. [Review]. Semin Arthritis Rheum 1991; 20: 273-84.
16. Jessop DS, Lightman SL, Chowdrey HS. Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus. J Neuroimmunol 1994; 49: 197-203.
17. Karalis K, Crofford L, Wilder RL, Chrousos GP. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology 1995; 136: 3107-12.
18. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-9.
19. Kira J, Harada M, Yamaguchi Y, Shida N, Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991; 102: 61-6.
20. Klapps P, Seyfert S, Fischer T, Scherbaum WA. Endocrine function in multiple sclerosis. Acta Neurol Scand 1992; 85: 353-7.
21. Levine S, Sowinski R, Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc Soc Exp Biol Med 1980; 165: 218-24.
22. MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989; 169: 431-45.
23. Mason D, MacPhee I, Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 1990; 70: 1-5.
24. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 1994; 79: 848-53.
25. Millac P, Book DB, Chase K. Endocrine function in multiple sclerosis. J Neurol Neurosurg Psychiatry 1969; 32: 414-8.
26. Mortimer CH. Gonadotropin-releasing hormone. In: Martini L, Besser GM, editors. Clinical Neuroendocrinology. New York: Academic Press, 1977: 213-36.
27. Neeck G, Federlin K, Graef V, Rusch D, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 24-9.
28. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinorrhythmometry. Chronobiologia 1979; 6: 305-23.
29. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989; 86: 7113-7.
30. Oppermann D. Safety of human and ovine corticotropin-releasing hormone [letter]. Lancet 1986; 2: 1031-2.
31. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
32. Purba JS, Raadsheer FC, Hofman MA, Ravid R, Polman CH, Kamphorst W, et al. Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology 1995; 62: 62-70.
33. Reder AT, Lowy MT. Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment. J Neurol Sci 1993; 117: 192-6.
34. Reder AT, Lowy MT, Meltzer HY, Antel JP. Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology 1987; 37: 849-53.
35. Reder AT, Makowiec RL, Lowy MT. Adrenal size is increased in multiple sclerosis. Arch Neurol 1994; 51: 151-4.
36. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759-65.
37. Rovaris M, Barnes D, Woodrofe N, du Boulay GH, Thorpe JW, Thompson AJ, et al. Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J Neurol 1996; 243: 536-42.
38. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992; 130: 1775-9.
39. Selye H. A syndrome produced by diverse nocuous agents. Nature (London) 1936; 138: 32.
40. Snyder BD, Lakatua DJ, Doe RP. ACTH-induced cortisol production in multiple sclerosis. Ann Neurol 1981; 10: 388-9.
41. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989a; 86: 2374-8.
42. Sternberg EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989b; 86: 4771-5.
43. Sternberg EM. Hyperimmune fatigue syndromes: diseases of the stress response? [editorial] [corrected] [published erratum appears in J Rheumatol 1993; 20: 925] [comment]. J Rheumatol 1993; 20: 418-21. Comment on: J Rheumatol 1993; 20: 469-74.
44. Sternberg EM. Hyperimmune fatigue syndromes: diseases of the stress response? [editorial] [corrected] [published erratum appears in J Rheumatol 1993; 20: 925] [comment]. J Rheumatol 1993; 20: 418-21. Comment on: J Rheumatol 1993; 20: 469-74.
45. Teasdale GM, Smith PA, Wilkinson R, Latner AL, Miller H. Endocrine activity in multiple sclerosis. Lancet 1967; 1: 64-8.
46. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
47. Thorpe JW, Halpin SF, MacManus DG, Barker GJ, Kendall BE, Miller DH. A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 1994; 36: 388-92.
48. Wender M, Gutowski J. Zur Frage der Funktion der Nebennierenrinde bei der Multiplen Sklerose. Wien Klin Wochenschr 1959; 71: 648-50.
49. Wenning GK, Wiethölter H, Schnauder G, Müller PH, Kanduth S, Renn W. Recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term, high-dose intravenous prednisolone therapy in patients with multiple sclerosis. Acta Neurol Scand 1994; 89: 270-3.